Skip to main content

Table 1 Outcome measures

From: Study protocol for “MOVEdiabetes”: a trial to promote physical activity for adults with type 2 diabetes in primary health care in Oman

 

Tool

When

Intervention

Comparison

Primary outcome

 GPAQ-MET-mins/week

Questionnaire

B, 3 F, 12 F

B, 3 F, 12 F

 Accelerometer (activePALTM)

Reporting step count, MET-min/week, and sitting time

B, 3 F, 12 F

B, 3 F, 12 F

 Pedometer (YAMAX Digi-walker SW-200)

Reporting step counts

B, 3 F, 12 F

-

Secondary outcomes

 Socio-demographic data

Questionnaire

B

B

 Height (m)

Stadiometer

B

B

 Body weight (Kg)

Calibrated scales

B, 3 F, 12 F

B, 3 F, 12 F

 Waist circumference (cm)

Tape measure

B, 3 F, 12 F

B, 3 F, 12 F

 Lipid profile (mmol/l)

Blood test (venous fasted sample)

B, 3 F, 12 F

B, 3 F, 12 F

 Blood pressure (mmHg)

Sphygmomanometer

B, 3 F, 12 F

B, 3 F, 12 F

aHbA1c (%)

Blood test (fasted sample)

B, 3 F, 12 F

B, 3 F, 12 F

 Self-assessed general health

Questionnaire

B, 3 F, 12 F

B, 3 F, 12 F

 Self-efficacy for PA

Questionnaire

B, 3 F, 12 F

B, 3 F, 12 F

 Social support for exercise

Questionnaire

B, 3 F, 12 F

B, 3 F, 12 F

 Cost analysis (description)

Detailed cost description

12 F

-

 Exit survey

Questionnaire (participants and project officers)

12 F

-

  1. (B = baseline; 3 F = 3 month follow-up, 12 F = 12 month follow-up)
  2. awhile blood collection for HbA1c at 12 month is mandatory, it is only done at baseline and 3 month if missing from the electronic health information system or recorded within more than 4 months prior to the measurement visits